Ulcerative colitis remission status after induction with mesalazine predicts maintenance outcomes: The MOMENTUM trial

On behalf of the Ulcerative Colitis Remission Study Group

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Ulcerative colitis remission status after induction with mesalazine predicts maintenance outcomes: The MOMENTUM trial'. Together they form a unique fingerprint.

Medicine & Life Sciences